Effect of abdominal obesity on insulin resistance and the components of the metabolic syndrome: Evidence supporting obesity as the central feature

Turkoglu C., Duman B., Gunay D., Cagatay P., Ozcan R., Buyukdevrim A.

OBESITY SURGERY, cilt.13, sa.5, ss.699-705, 2003 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 13 Sayı: 5
  • Basım Tarihi: 2003
  • Doi Numarası: 10.1381/096089203322509255
  • Dergi Adı: OBESITY SURGERY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.699-705
  • İstanbul Üniversitesi Adresli: Evet

Özet

Background: Metabolic syndrome includes abdominal obesity, diabetes type 2, hypertension, dyslipidemia, derangements of fibrinolysis, and atherosclerosis. Since abdominal obesity is one of the major components of the insulin resistance syndrome (IRS), an attempt was made to evaluate the interrelationships between the magnitude of obesity and the components of the syndrome.